Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of total secondary ginseng glucoside in preparation of medicine for treating and/or preventing abnormal lipids metabolism after myocardial ischemia

A technology for abnormal lipid metabolism and total ginsenosides, which is applied in the field of medicine and can solve problems such as weak action strength

Inactive Publication Date: 2016-08-17
SHANGHAI HONGYITANG BIOPHARM CO LTD
View PDF2 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

These secondary saponins have many new activities, for example: ginseng secondary saponins Rh1, Rh2, Rg3 have obvious anti-cancer activity, can induce re-differentiation of cancer cells, can induce cancer cells to re-differentiate into healthy cells, other saponins body has no such effect, or the effect is weaker

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of total secondary ginseng glucoside in preparation of medicine for treating and/or preventing abnormal lipids metabolism after myocardial ischemia
  • Application of total secondary ginseng glucoside in preparation of medicine for treating and/or preventing abnormal lipids metabolism after myocardial ischemia
  • Application of total secondary ginseng glucoside in preparation of medicine for treating and/or preventing abnormal lipids metabolism after myocardial ischemia

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0046] 1. Experimental steps

[0047] 1.1 Experimental materials

[0048] Total ginseng glycosides (prepared according to the method disclosed in ZL200510083855.6); diltiazem hydrochloride tablets (Tianjin Tanabe Pharmaceutical Co., Ltd.); isoproterenol (Sigma, St.Louis, MO, USA); creatine kinase (CK), aspartate Transaminase (AST), lactate dehydrogenase (LDH) kits (Sinobio Biotechnology Co., Ltd.); superoxide dismutase (SOD) and malondialdehyde (MDA) kits (Nanjing Jiancheng Technology Co., Ltd.) .

[0049] All lipid reference substances and internal standards were purchased from Avanti Company with a purity >98%; methyl tert-butyl ether (HPLC grade, J.T.Baker); acetonitrile (MS grade, J.T.Baker); methanol (pesticide residue grade, J.T. Baker); isopropanol, chloroform (both HPLC grade, Burdick & Jackson); ammonium formate, ammonium acetate (both HPLC grade, Sigma); formic acid (HPLC grade, TEDDIA); deionized water was prepared using a Millipore water purifier.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to an application of total secondary ginseng glucoside, Rg3, Rg5 and / or Rk1 in preparation of a medicine for treating and / or preventing abnormal lipids metabolism after myocardial ischemia, and concretely relates to an application of total secondary ginseng glucoside, Rg3, Rg5 and / or Rk1 in preparation of the medicine for regulating fatty acid, sphingolipid, phosphoglyceride and glyceride levels in blood or cardiac muscle tissue after myocardial ischemia. The application of the invention makes a research of the protective effects of total secondary ginseng glucoside to heart of mice with myocardial ischemial injury from an angle of lipidomics, reveals mechanism of total secondary ginseng glucoside, and provides a brand new approach for treating myocardial ischemial injury.

Description

technical field [0001] The present invention relates to the field of medicine, in particular to the application of ginsenosides, Rg3, Rg5 and / or Rk1 in the preparation of drugs for treating and / or preventing abnormal lipid metabolism after myocardial ischemia. Background technique [0002] Ginseng is the dried root of Araliaceae plant Panax ginseng C.A.Mey. Ginseng is an important medicine for invigorating Qi in traditional Chinese medicine. Nature, flavor and meridian distribution: sweet, slightly bitter, neutral. Functions and indications: tonify vital energy, restore pulse and solidify, invigorate the spleen and lung, promote body fluid, and soothe the nerves. For physical weakness, cold limbs, slight pulse, spleen deficiency, lack of food, lung deficiency, wheezing and coughing, body fluid wound thirst, internal heat and thirst, prolonged illness and deficiency, palpitations and insomnia, impotence and cold uterus; heart failure, cardiogenic shock. Panax notoginseng i...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/258A61K31/704A61P9/10A61P3/06
Inventor 熊慧
Owner SHANGHAI HONGYITANG BIOPHARM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com